If you are looking for an Ozempic to Mounjaro conversion chart, there is no validated or regulator approved chart that tells you which Mounjaro dose is equivalent to a particular Ozempic dose. Ozempic contains semaglutide, while Mounjaro contains tirzepatide. They are different medicines that act on different receptor targets.
That means 1 mg of one medicine cannot simply be matched to a certain number of milligrams of the other. There is no established Ozempic 1 mg equivalent to Mounjaro, no 1 mg Ozempic equivalent to Mounjaro figure, and no Ozempic 1 mg to Mounjaro strength that you can safely look up and use yourself.
What does exist is a proper approach to switching. A prescriber considers your current dose, how long you have been taking it, how you have tolerated it, why you are switching and whether you are using the medicine for type 2 diabetes or weight management. The MHRA advises people to speak to a healthcare professional before switching between GLP 1 medicines because the medicines differ in strength, use and licensed indications.
Both Ozempic and Mounjaro are once weekly injections. Ozempic contains semaglutide, a GLP 1 receptor agonist. Mounjaro contains tirzepatide, which acts on both the GLP 1 and GIP receptors. In the UK, Ozempic is licensed for type 2 diabetes, while Mounjaro is licensed for type 2 diabetes and weight management in eligible adults.
The dosing ranges are also different. Ozempic starts at 0.25 mg once weekly and can be increased to 0.5 mg, 1 mg and 2 mg at intervals set out in its product information. Mounjaro starts at 2.5 mg once weekly, increases to 5 mg after four weeks, and can then be increased in 2.5 mg steps at intervals of at least four weeks. The maximum adult dose is 15 mg once weekly.
These different numbers do not mean that Mounjaro is simply a stronger version of Ozempic. They reflect the fact that the medicines are different molecules with different dosing systems.
It is also important to consider your medical history, current health and other medicines before switching. This is particularly important if you take insulin or a sulphonylurea for diabetes, as changes to treatment may affect the risk of low blood sugar.
Key Things to Know About Ozempic 1 mg Equivalent to Mounjaro and Switching Medications
- Semaglutide, the active ingredient in Ozempic, acts on the GLP 1 receptor. Tirzepatide, the active ingredient in Mounjaro, acts on both the GLP 1 and GIP receptors.
- There is no validated or regulator approved Ozempic to Mounjaro dose equivalence chart. The different medicines cannot be matched simply by milligrams.
- Switching from Ozempic to Mounjaro should be planned with a prescriber. The Mounjaro product information has its own starting and dose escalation schedule, but the appropriate plan when switching depends on the individual patient.
- Ozempic is licensed in the UK for type 2 diabetes. Mounjaro is licensed for type 2 diabetes and weight management in eligible patient groups.
- Online conversion charts should be treated with caution because there is no established dose equivalence between the two medicines.
- A balanced diet and appropriate physical activity form part of treatment for the licensed uses of these medicines. If you have diabetes, your blood glucose management also needs to be considered when changing treatment.
- Both medicines are given once weekly, but they have different dose ranges and titration schedules.
- Speak to your prescriber before switching. The MHRA specifically advises people to seek healthcare professional advice before changing from one GLP 1 medicine to another.
- Starting Mounjaro at the dose recommended by your prescriber allows the treatment to follow its approved dosing schedule and gives the clinician an opportunity to consider how you respond to it.
- If you take insulin or a sulphonylurea, tell your prescriber because your diabetes medicines may need to be reviewed when treatment changes.
The important point is simple: switching is about choosing an appropriate starting plan, not doing a calculation between two different medicines.
Quick Answers
| The question | The answer |
|---|---|
| Is there an Ozempic to Mounjaro conversion chart? | No validated or regulator approved chart gives an equivalent dose. |
| What is 1 mg of Ozempic equivalent to in Mounjaro? | There is no established equivalent dose. |
| What Mounjaro dose replaces Ozempic 1 mg? | There is no automatic replacement dose. A prescriber decides where to start based on your treatment history and clinical circumstances. |
| Do I start Mounjaro where I left off? | Not automatically. Mounjaro has its own starting and dose escalation schedule. |
| Is Ozempic to Wegovy different? | Yes. Both contain semaglutide, so the medicines share the same active ingredient, although their licensed uses, strengths and dosing schedules differ. |
| How do I actually switch? | Speak to a prescriber. They can review your last Ozempic dose, timing, reason for switching and other medicines before setting a Mounjaro plan. |
Why Milligrams Do Not Convert
This is worth understanding because it explains why a conversion chart can be misleading.
A milligram measures the amount of a substance by weight. It does not tell you how strong the effect of a medicine will be. Two different medicines can have very different effects at completely different doses.
Semaglutide is a GLP 1 receptor agonist. Tirzepatide acts on both the GLP 1 and GIP receptors. They therefore do not work through exactly the same pathway.
So an Ozempic to Mounjaro conversion chart would need to establish a clinically useful relationship between two different medicines. The UK product information does not provide one.
That is why questions such as "What is Ozempic 1 mg equivalent to in Mounjaro?" cannot be answered by simple arithmetic.
The same applies in reverse. Searching for "5 mg Mounjaro equivalent to Ozempic", "Mounjaro 2.5 mg equivalent to Ozempic" or "10 mg Mounjaro equivalent to Ozempic" does not produce a dose that you can safely use as a direct substitute.
Both medicines can be used in diabetes care, and Mounjaro is also licensed for weight management in eligible adults. However, their mechanisms, licensed uses and dosing schedules are different.
What the Two Ladders Actually Look Like
What are the doses of Mounjaro? That is a fair question. Looking at the two dosing schedules side by side helps explain why the numbers should not be matched.
| Ozempic (semaglutide) | Mounjaro (tirzepatide) | |
|---|---|---|
| Acts on | The GLP 1 receptor | GLP 1 and GIP receptors |
| Licensed in the UK for | Type 2 diabetes | Type 2 diabetes and weight management in eligible patient groups |
| Available weekly strengths | 0.25 mg, 0.5 mg, 1 mg, 2 mg | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
| Frequency | Once weekly | Once weekly |
| Starting dose | 0.25 mg once weekly | 2.5 mg once weekly |
| Dose increases | After at least four weeks at the current dose, where appropriate | After at least four weeks at the current dose, where appropriate |
Ozempic's product information starts treatment at 0.25 mg once weekly, followed by 0.5 mg after four weeks. The dose can then be increased to 1 mg and, where appropriate, 2 mg after at least four weeks at the current dose.
Mounjaro starts at 2.5 mg once weekly. After four weeks, the dose is increased to 5 mg, with further 2.5 mg increases possible after at least four weeks on the current dose. The maximum adult dose is 15 mg once weekly.
Notice that the numbers do not occupy the same range. That does not mean one medicine is a fixed number of times stronger than the other. The figures belong to different medicines and cannot be compared as if they were on one shared scale.
Anyone concluding that Mounjaro 5 mg is equivalent to Ozempic 1 mg, or that Mounjaro 2.5 mg is equivalent to Ozempic 0.5 mg, is making a comparison that is not supported by an approved dose conversion system.
The reverse questions have the same issue. "5 mg of Mounjaro is equivalent to how much Ozempic?", "7.5 mg Mounjaro equals how much Ozempic?" and "10 mg Mounjaro is equivalent to how much Ozempic?" do not have an established conversion answer.
What Actually Happens When You Switch
How to transition from Ozempic to Mounjaro is a real clinical question, but it is not answered by converting one number into another.
The MHRA advises patients to consult a healthcare professional before switching between GLP 1 medicines. The clinician can consider your current treatment, the reason for the switch, your response to treatment and any other medicines you take.
Mounjaro has its own initiation schedule. The product information states that the starting dose is 2.5 mg once weekly for four weeks, followed by 5 mg once weekly. Further increases can be made in 2.5 mg steps after at least four weeks on the current dose.
That does not mean every person changing from Ozempic must follow exactly the same switching plan. Your prescriber needs to decide how the approved Mounjaro schedule should be applied to your circumstances.
A few points are worth remembering:
- Previous experience with Ozempic does not create a simple Mounjaro dose equivalent.
- Tolerating one medicine does not guarantee that you will have the same experience with another medicine.
- Tirzepatide acts on both GLP 1 and GIP receptors, while semaglutide acts on the GLP 1 receptor.
- Starting or increasing Mounjaro should follow the instructions given by your prescriber.
- If you take insulin or a sulphonylurea, your diabetes treatment may need particular attention because changes can affect the risk of hypoglycaemia.
A prescriber may take your previous dose and treatment history into account when planning the switch, but there is no general conversion rule that patients can apply themselves.
Timing between the two
Both medicines are given once a week, but the timing of a switch should be planned by the healthcare professional managing your treatment.
The MHRA advises people to speak to a healthcare professional before switching between GLP 1 medicines because the medicines differ in strength, how they are used and the conditions they are licensed to treat. Switching without medical advice may increase the risk of side effects or make treatment less effective.
Tell your prescriber exactly when you last used Ozempic and what dose you were taking. This gives them the information they need to plan the change.
It is also important not to create an overlap yourself or take extra doses to try to make up for a difference between the medicines. Follow the switching instructions you are given.
Why an Ozempic to Mounjaro Conversion Chart Can Be Risky, Not Just Inaccurate
It is worth being specific about why these charts can cause problems.
A chart can look authoritative even when it is based on assumptions rather than an approved dosing system. If someone uses an unofficial conversion to choose a Mounjaro dose without medical advice, they could end up taking a dose that does not match the approved Mounjaro initiation schedule or their individual circumstances.
Higher doses of these medicines can cause gastrointestinal side effects such as nausea, vomiting and diarrhoea. The MHRA has also issued safety advice about the risk of acute pancreatitis with GLP 1 medicines and dual GLP 1 and GIP medicines.
This is why questions such as "What is the Mounjaro equivalent to Ozempic 2 mg?" should not be answered with an unofficial number.
If you are changing treatment, the safer approach is to give your prescriber the exact details of your current medicine and let them set the new dose.
Ozempic Is Not the Weight Loss Semaglutide
This distinction matters because Ozempic and Wegovy contain the same active ingredient but have different licensed uses.
Ozempic contains semaglutide and is licensed in the UK for the treatment of type 2 diabetes. Wegovy also contains semaglutide but is licensed for weight management in eligible people. Mounjaro is licensed for both type 2 diabetes and weight management in eligible patient groups.
Ozempic may sometimes be prescribed outside its licensed indication in clinical practice, but the MHRA advises that medicines should be used according to their licensed indications unless there is an appropriate clinical reason for another prescribing decision.
If your main reason for treatment is weight management rather than blood glucose control, say this clearly during your assessment. It helps the prescriber consider which licensed treatment options are appropriate.
The Mounjaro injection for weight loss page sets out what that route involves.
The One Comparison With Any Basis
Ozempic to Wegovy conversion chart is a different question because both medicines contain semaglutide.
The same active ingredient means there is a stronger basis for understanding the relationship between the medicines than there is between semaglutide and tirzepatide. However, that still does not mean you should move between Ozempic and Wegovy by simply matching numbers.
The two products have different licensed indications, strength ranges and dosing schedules. Wegovy's dosing for weight management follows its own titration schedule, so a prescriber still needs to decide how a switch should be made.
The important difference is that Ozempic and Wegovy contain the same active ingredient. Ozempic and Mounjaro do not.
What To Tell Your Prescriber
A safe switch starts with giving your prescriber a clear picture of your current treatment. Tell them:
- The exact medicine you are using, including the dose and how long you have been taking it.
- The date of your last injection.
- How long you stayed on each dose.
- Any side effects you experienced and whether they affected your day to day life.
- Why you are considering a switch, such as side effects, supply problems, cost or treatment response.
- Whether you are being treated for type 2 diabetes and who manages your diabetes care.
- All other medicines you take, especially insulin or medicines that can lower blood glucose.
This information helps your prescriber decide how to approach the change. It is especially important if you are using other diabetes medicines because the risk of low blood sugar may need to be considered.
Do not change the dose yourself based on an online conversion chart. If you are unsure about the dose or timing of your next injection, check with your prescriber or pharmacist.
What To Expect in the First Weeks
The first few weeks after a change can feel different from your previous treatment. Everyone responds differently, so it is better to know what to watch for rather than expect a particular result.
- Nausea, diarrhoea, vomiting and other digestive symptoms can occur with these medicines, particularly during dose increases.
- Your appetite may feel different after changing medicines because tirzepatide and semaglutide do not have exactly the same mechanism.
- Your weight or blood glucose readings may change at a different pace after the switch.
- Smaller meals and paying attention to how your body responds can be useful if you experience digestive symptoms.
- Constipation can also occur with these medicines. Keeping your fluid intake adequate and following the dietary advice given by your healthcare professional may help.
- If you have diabetes, continue to follow the blood glucose monitoring advice given by your diabetes team.
If you have severe or persistent symptoms, particularly repeated vomiting, difficulty keeping fluids down or severe persistent abdominal pain, contact a healthcare professional promptly. The MHRA advises patients and clinicians to be alert to severe persistent stomach pain that may spread to the back as a possible sign of acute pancreatitis.
Comparing weight loss treatment options with a prescriber can also help if the new treatment is not suiting you.
